Combined Biomarker Analysis For Prediction Of Pathological Complete Response (Pcr) After 12 Weeks Of Pembrolizumab + Trastuzumab + Pertuzumab In Her2-Enriched Early Breast Cancer: Keyriched-1 Trial
Pembrolizumab;Pertuzumab;Trastuzumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Combined Biomarker Analysis For Prediction Of Pathological Complete Response (Pcr) After 12 Weeks Of Pembrolizumab + Trastuzumab + Pertuzumab In Her2-Enriched Early Breast Cancer: Keyriched-1 Trial ### Output: Pembrolizumab;Pertuzumab;Trastuzumab